Mon.Nov 06, 2023

article thumbnail

Around 14% of Americans Have Experienced Long COVID Symptoms

Drug Topics

Although long COVID has emerged as a major public health concern, it has not yet been clearly identified as a clinical condition.

662
662
article thumbnail

The thorniest questions facing pharma, according to a leading bioethicist

PharmaVoice

Bioethics guru Arthur Caplan of NYU gives his outspoken and frank opinion on the industry’s minefield of ethical challenges.

246
246
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Delta-8 THC Accessibility, Marketing to Minors Cause for Concern

Drug Topics

Unlike traditional THC, which is federally banned, D8 has managed to find a legal loophole, making it widely accessible.

468
468
article thumbnail

AI in Biomedical Research Is Revolutionizing Drug Development, Clinical Innovation

Pharmacy Times

AI is expected to significantly quicken the pace of drug design and development, while improving the success rate of new medicines.

176
176
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

What Pharmacies Can Expect From Medication Synchronization Programs

Drug Topics

Tiffany Capps, CPhT, pharmacy operations manager at Galloway-Sands Pharmacy in North Carolina and marketing communications manager at CPESN, discusses how pharmacies can utilize med sync programs and what they can expect when implementing one.

CPhT 247
article thumbnail

Researchers Create App to Predict Whether Child in Acute Liver Failure Will Need Transplant

Pharmacy Times

Children with a score of higher than 30 on the CHALF Score scale will need an emergency transplant.

158
158

More Trending

article thumbnail

Staying Ahead of Headache Management: Tips for Pharmacists on Patient Recommendations

Pharmacy Times

Pharmacists can play a vital role in educating patients about headaches and can help to limit their impact on the patient.

145
145
article thumbnail

As extreme heat soars, laws to protect outdoor workers are bubbling up — and facing resistance

STAT

As weather starts to cool in much of the country, the heat-baked cement and sweaty afternoons from this summer fade from collective memory. But activists and labor groups representing outdoor workers haven’t forgotten. They are pushing lawmakers and regulators to keep facing the heat. On Tuesday, the Miami-Dade Board of County Commissioners will take a final vote on a proposed heat standard to protect outdoor workers.

142
142
article thumbnail

The Ketogenic Diet Could Be an Effective Lifestyle Approach to Manage Advanced-Stage Chronic Kidney Disease, Diabetes

Pharmacy Times

A low carbohydrate diet plus a sodium glucose contransporter-2 (SGLT2) inhibitor was found to be safe and effective for weight loss and glycemic control in patients with diabetes and chronic kidney disease.

139
139
article thumbnail

Alliance for mRNA Medicines Officially Launched in Germany

BioPharm

The Alliance for mRNA Medicines (AMM) was officially launched at the 11th International mRNA Health Conference in Berlin, Germany.

133
133
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Benefits, Mechanisms of SGLT2 Inhibitors in Diabetic Kidney Disease, Other Communities

Pharmacy Times

Although SGLT2 inhibitors are not a cure of diabetic kidney disease, this treatment can help reduce the risk and manage the disease either alone or with complementary therapies.

139
139
article thumbnail

MA enrollees have fewer hospitalizations, Harvard study finds

Fierce Healthcare

Medicare Advantage (MA) beneficiaries have better quality of care and health outcomes than traditional fee-for-service counterparts, researchers from Harvard Medical School found. | Another white paper released by Inovalon and Harvard Medical School highlights the benefits Medicare Advantage enrollees enjoy over traditional Medicare counterparts.

article thumbnail

Study: Risk of Atrial Fibrillation Remains High After 3 Years, Including Those With Heart Failure

Pharmacy Times

Risk of atrial fibrillation with 1 of the independent predictors, including congestive heart failure and left atrial enlargement, resulted in greater than a 4-fold increased detection.

132
132
article thumbnail

The obesity drug effect: What medical device executives are saying

PharmaVoice

Investor concerns that interest in GLP-1s will slow demand for medical devices and procedures have shaved roughly $370 billion in value from stocks across the medtech sector, according to research by Mizuho.

130
130
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

How over-investment is killing digital health companies

pharmaphorum

How over-investment is killing digital health companies Mike.

128
128
article thumbnail

Clinical Overview: Treatment Options for Premenstrual Syndrome (PMS)

Pharmacy Times

Treatment options for individuals impacted with PMS can vary and include lifestyle modifications, medication treatments, and herbal products.

123
123
article thumbnail

Anthropy23, part one: The future of AI, the future of Britain

pharmaphorum

Anthropy23, part one: The future of AI, the future of Britain Mike.

122
122
article thumbnail

Cigna explores selling Medicare Advantage business: report

Fierce Healthcare

Cigna is looking into the possibility of selling its Medicare Advantage (MA) business, according to a report from Reuters. | Cigna may decide to sell off its Medicare Advantage business. The insurer is reportedly in early discussions with an investment bank to go over its options.

Insurance 119
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Drug combos from AZ, Boehringer show promise in CKD

pharmaphorum

Drug combos from AZ, Boehringer show promise in CKD Phil.

121
121
article thumbnail

STAT+: Data backing prescription digital therapeutics found lacking in rigor, inclusivity

STAT

The fast-evolving world of digital therapeutics offers the promise of lowering barriers to accessing health care, but the companies behind these software-based tools face an uphill battle in convincing clinicians and insurers that their products can complement traditional medicine. That debate has largely focused on the quality of evidence backing these prescription digital therapies.

Insurance 117
article thumbnail

UK patient data project reaches one million volunteers

pharmaphorum

UK patient data project reaches one million volunteers Phil.

119
119
article thumbnail

STAT+: Vertex may face another battle in the U.K. over the value of its cystic fibrosis medicines

STAT

Once again, Vertex Pharmaceuticals and a U.K. government agency are at odds over the value of life-saving cystic fibrosis medicines. In draft guidance published late last week, the National Institute for Health and Care Excellence stated that a groundbreaking treatment called Trikafta and two other cystic fibrosis medications sold by the company offer notable clinical benefits, but are not cost-effective.

117
117
article thumbnail

Kaiser Permanente logs $239M net income, 0.6% operating margin in Q3 2023

Fierce Healthcare

Kaiser Permanente pulled in $239 million in net income during the third quarter of 2023, a turnaround from the $1.5 billion net loss the integrated system had seen a year prior. | The massive integrated nonprofit's $156 million operating income turns around the $75 million operating loss of the third quarter of 2022 but is a slight pullback from 2023's prior quarters.

116
116
article thumbnail

Lights Lacquer gets in holiday spirit via Cabin Fever collection

Drug Store News

Inspired by the rustic allure of a cozy cabin retreat, the line’s color palette draws inspiration from the serene beauty of a vintage winter wonderland, the brand stated.

115
115
article thumbnail

STAT+: Astellas shows enough data for eye treatment to support expanded use, but still lags competitor

STAT

Astellas on Saturday presented study results showing an increased treatment effect over time for its approved medicine for a common type of vision loss. The new data are probably enough to convince the Food and Drug Administration to remove restrictions on the drug’s use, but they still don’t measure up to a competing treatment from Apellis Pharmaceuticals.

114
114
article thumbnail

Bayer doubles down on Factor XIa with new phase 3 trial

pharmaphorum

Bayer doubles down on Factor XIa with new phase 3 trial Phil.

113
113
article thumbnail

CVS Pharmacy expands OTC hearing aid offerings

Drug Store News

Three OTC hearing aids are now available at more than 1,000 locations across 39 states, with select models also available for purchase online.

111
111
article thumbnail

FDA approves Wezlana for inflammatory conditions

The Checkup by Singlecare

Those on immunosuppressive drugs for psoriasis or ulcerative colitis may soon breathe a little easier when they get to the pharmacy counter: The U.S. Food and Drug Administration (FDA) just approved Wezlana (ustekinumab-auub), a biosimilar for the popular drug Stelara. Manufactured by Amgen, the biosimilar—which is like a generic for biologic medications—was approved to treat inflammatory conditions like plaque psoriasis or ulcerative colitis.

FDA 110
article thumbnail

Will holiday sales be ho, ho, ho or ho hum?

Drug Store News

This year’s early holiday season appears off to a slow start, per a Placer.ai analysis, which notes that retailers might need to get creative to convince shoppers to walk through their doors.

111
111
article thumbnail

STAT+: Government looks to tinker with new caps on Medicare Advantage broker payments

STAT

The federal government is proposing to rein in health insurance companies that entice brokers with lavish bonuses to sell their Medicare Advantage plans by placing a firmer cap on broker compensation. However, even with new guardrails in place, agents and brokers will still have strong financial incentives to move people into Medicare Advantage plans instead of pitching supplemental coverage for the traditional Medicare program.

article thumbnail

Hy-Vee dietitians to offer 1,500 free A1C screenings in November

Drug Store News

Hy-Vee will offer a variety of events throughout November to promote National Diabetes Month.

106
106
article thumbnail

In experiment, electrical stimulation of the spinal cord helps a patient with Parkinson’s to walk

STAT

An experimental treatment that delivers an electrical current to the spinal cord appeared to notably improve the ability of a man with Parkinson’s to keep his balance and walk without freezing up, a development that experts say could be a dramatic advance if it is found to deliver similar benefits in larger studies. The volunteer, identified as Marc, a 62-year-old who has had Parkinson’s for 30 years, spoke on a call with reporters last week.

109
109
article thumbnail

Amazon: Let the holiday shopping begin

Drug Store News

Amazon is kicking off its Black Friday event starting Nov. 17, with Cyber Monday deal to follow, Nov. 25-Nov. 27.

106
106